Meteora Capital’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.73M Sell
343,722
-64,997
-16% -$700K 0.27% 98
2025
Q4
$4.37M Buy
408,719
+157,689
+63% +$1.68M 0.37% 81
2025
Q3
$2.66M Sell
251,030
-1,675,969
-87% -$17.7M 0.28% 81
2025
Q2
$20.3M Buy
+1,926,999
New +$20.2M 3.77% 5

Other funds holding GPAT

Meteora Capital's GPAT Position: Q1 2026 in Review

Meteora Capital reduced its GP-Act III Acquisition Corp (GPAT) stake by 16% in Q1 2026, selling an estimated $700K and leaving 343,722 shares worth $3.73M. The position accounts for 0.27% of the portfolio, ranked #98.

Meteora Capital first reported a position in GPAT in Q2 2025 and has held it in 4 quarters since. The position peaked at $20.3M in Q2 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Meteora Capital held 343,722 shares of GP-Act III Acquisition Corp worth $3.73M as of Q1 2026.
  • Meteora Capital sold 64,997 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $700K.
  • GP-Act III Acquisition Corp made up 0.27% of Meteora Capital's portfolio in Q1 2026, its #98 holding.
  • Meteora Capital first reported a position in GP-Act III Acquisition Corp in Q2 2025 and has held it in 4 quarters since.
  • Meteora Capital's GP-Act III Acquisition Corp position peaked at $20.3M in Q2 2025.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.